Perspective on Alpha-Gal Syndrome Managed With Omalizumab for Perioperative Optimization of Total Hip Arthroplasty
JBJS Case Connector · 2026-10 · 16 (4)
DOI: 10.2106/jbjs.cc.26.00129 ↗Kurz gefasst
Fachartikel in der Zeitschrift JBJS Case Connector, 2026-10. Verfasst von Andriy Kobryn und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York.
- Department of Orthopaedics and Physical Performance, University of Rochester Medical Center, Rochester, New York.
ORCID-Profile: Andriy Kobryn, Edward M Schwarz
Zitieren
APA
Kobryn, A., & Schwarz, E. M. (2026). Perspective on Alpha-Gal Syndrome Managed With Omalizumab for Perioperative Optimization of Total Hip Arthroplasty. JBJS Case Connector, 16(4). https://doi.org/10.2106/jbjs.cc.26.00129
Vancouver
Kobryn A, Schwarz EM. Perspective on Alpha-Gal Syndrome Managed With Omalizumab for Perioperative Optimization of Total Hip Arthroplasty. JBJS Case Connector. 2026;16(4). doi:10.2106/jbjs.cc.26.00129
BibTeX
@article{Kobryn2026,
author = {Kobryn, Andriy and Schwarz, Edward M},
title = {Perspective on Alpha-Gal Syndrome Managed With Omalizumab for Perioperative Optimization of Total Hip Arthroplasty},
journal = {JBJS Case Connector},
year = {2026},
volume = {16},
number = {4},
doi = {10.2106/jbjs.cc.26.00129}
}
EUVIMED